Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183235 · ClinicalTrials.gov registry record · Phase 2
Aripiprazole Effects on Alcohol Reactivity and Consumption
A Phase 2 study of Alcohol Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00183235 is a Phase 2 study of Alcohol Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 30 participants, below the 313-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00183235, a Phase 2 study of Alcohol Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether aripiprazole (marketed dopamine stabilizer) is effective in reducing of alcohol craving compared to placebo.
Conditions Studied
Interventions
- DRUG aripiprazole (up to 15 mg/day) for 8 days
Study Locations (1)
South Carolina
- Center for Drug and Alcohol Programs, Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183235
The ClinicalTrials.gov registry entry for NCT00183235 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 313-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (90% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcohol Dependence appearing as the primary indexed condition, and to 1 intervention - of which aripiprazole (up to 15 mg/day) for 8 days is the first listed.
NCT00183235 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT00183235 about?
NCT00183235 is a clinical study titled "Aripiprazole Effects on Alcohol Reactivity and Consumption". The purpose of this study is to determine whether aripiprazole (marketed dopamine stabilizer) is effective in reducing of alcohol craving compared to placebo.
What is the current status of trial NCT00183235?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2005-06. Estimated completion is 2006-02.
What conditions does trial NCT00183235 study?
This clinical trial studies the following conditions: Alcohol Dependence.
What interventions are being tested in trial NCT00183235?
The interventions under investigation include: aripiprazole (up to 15 mg/day) for 8 days (DRUG).
Who is sponsoring clinical trial NCT00183235?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183235 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
Gabapentin Treatment of Alcohol Dependence
COMPLETED · Phase 2
-
The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)
COMPLETED · Phase 2
-
Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence
COMPLETED · Phase 2
-
A Therapeutic Workplace for Alcohol Dependence
COMPLETED · Phase 2
-
Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.